Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

Unapproved stem cell therapies are marketed online in the UK, raising safety and regulation concerns.

Engineering the cell microenvironment is key for advancing tissue engineering and regenerative medicine.

Recent findings in cell biology help understand cell roles in health and disease.

Single-cell sequencing can improve livestock health and productivity but faces challenges in precise cell analysis.

Biomimetic synthetic vesicles could improve precision medicine by combining natural and synthetic benefits.

Epithelial-derived Pop-Up Keratinocytes (ePUKs) may enhance wound healing in regenerative medicine.

Functionalized bacterial cellulose can improve medical tissue engineering.

The device applies substances directly to body tissues, improving cell transplant and treatment processes.

Continuous microfluidic processes can help scale up microtissue production for industrial and clinical use.

3D bioprinting could solve organ shortages and improve drug testing.

3D cell cultures produce extracellular vesicles similar to those in the body.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

New cell sources for bone tissue engineering are promising due to easier harvesting and availability.

Stem cell technologies are mostly effective in treating diseases and repairing tissues.

We need to understand more about regeneration to improve human tissue healing.

Engineered polypeptide-based systems can improve cancer treatment by targeting specific sites and reducing side effects.

Cell-based therapies show promise for treating Limbal Stem Cell Deficiency but need more research.

Exosome-based therapies in dermatology show promise but face challenges in standardization, regulation, and safety.

Biomaterials combined with stem cells show promise for improving tissue repair and medical treatments.

Flexible bioelectronics show promise in non-invasive cancer detection and treatment but need improvements in stability and effectiveness.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Hair follicles and urine cell pellets are promising for transcriptome studies.

The document emphasizes the importance of ongoing research and ethical considerations in genome editing and cellular reprogramming.

Gene and cell therapies are being developed to treat rare skin conditions like epidermolysis bullosa and ichthyosis.

Keratin-based biomaterials are promising for wound healing, drug delivery, and nerve regeneration due to their biodegradability and biocompatibility.

Evidence-based medicine needs improvement to better tailor treatments to individual patients.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.